Signaling by Type I Interferons in Immune Cells: Disease Consequences

Cancers (Basel). 2024 Apr 22;16(8):1600. doi: 10.3390/cancers16081600.

Abstract

This review addresses interferon (IFN) signaling in immune cells and the tumor microenvironment (TME) and examines how this affects cancer progression. The data reveal that IFNs exert dual roles in cancers, dependent on the TME, exhibiting both anti-tumor activity and promoting cancer progression. We discuss the abnormal IFN signaling induced by cancerous cells that alters immune responses to permit their survival and proliferation.

Keywords: B cells; NK cells; T cell; cancer; dendritic cell; immune cells; interferons; macrophage; neutrophils; signaling; tumor microenvironment.

Publication types

  • Review

Grants and funding

The research of LCP is supported by grant R01-CA77816 by the NIH.